Back to the archive

The encyclopedia · R&D & Science · Technical decision · 1996–2009

The anesthesiologist who invented 21 studies — and changed how millions were treated

Scott Reuben never conducted the trials he published. He invented patients and forged co-authors — his faked data shaped post-surgery care for millions.

Baystate Medical Center · Tufts University · 2009-03-10

What happened

Scott Reuben was a star in anesthesiology — a professor at Tufts University, chief of acute pain at Baystate Medical Center in Massachusetts, and the author of dozens of influential studies on pain management. His research claimed to show that certain painkillers, particularly Pfizer's Celebrex, were effective for post-surgical pain with few side effects. His findings changed how millions of patients were treated after orthopedic surgery.

In May 2008, Baystate conducted a routine audit and discovered that Reuben had not obtained approval for two studies he planned to present during the hospital's research week. The audit unraveled everything: Reuben had fabricated data in 21 journal articles dating back to at least 1996. He had never conducted the clinical trials. In some cases, he invented the patients. He forged the names of co-authors who had no knowledge of the studies. The fraud was discovered only because he failed to get internal approval for two new studies — the published research had never been audited at all.

Reuben admitted the fraud in March 2009. He pleaded guilty to health care fraud in 2010 and was sentenced to six months in federal prison, fined $5,000, and ordered to pay $360,000 in restitution to the pharmaceutical companies whose grants he had taken. His medical license was permanently revoked, and the FDA permanently debarred him from working on drug applications. Scientific American called him the medical equivalent of Bernie Madoff.

Why it happened

  • Reuben's studies always produced the results his sponsors wanted — and no one asked to see the raw data because the results were commercially convenient.
  • Baystate's routine audit was triggered by a paperwork issue, not by scientific suspicion — the published research had never been scrutinized for fabrication.
  • The pharmaceutical companies that funded Reuben's work had no incentive to check his methods; his studies supported their products and their marketing claims.
  • Peer review failed because the results were plausible and the author was a well-known authority in the field — the system trusts the person, not the data.
What it cost21 retracted studies, $360K restitution, prisonembarrassing

The lesson

A system that trusts authority over data will be exploited until someone audits the work. Reuben's fraud was caught by a paperwork check, not by peer review, replication, or any scientific safeguard.

Aftermath

The Reuben scandal was one of the largest cases of research fraud in anesthesiology. His fabricated data had influenced treatment guidelines for post-surgical pain management worldwide. An estimated 'billions of dollars' worth of drugs' were prescribed based on his findings. The case led to increased scrutiny of industry-funded pain research and contributed to broader reforms in clinical trial registration and data transparency. It also highlighted the vulnerability of a system where a single researcher's unverified claims could alter medical practice for millions of patients.

Sources

spotted an error? The club wants to know.

Comments · 0

    Sign in to join the comments.

    More like this

    Somewhere, someone solved the problem this company failed at. 2nd Opinion →